2025-523641-10-00招募中1 期
PHARMACOKINETICS OF PETRELINTIDE FOLLOWING ADMINISTRATION TO PARTICIPANTS WITH IMPAIRED HEPATIC FUNCTION
Zealand Pharma A/S3 个研究点 分布在 2 个国家目标入组 36 人开始时间: 2026年5月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 36
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Information Desk
Scientific
Zealand Pharma A/S
研究点 (3)
Loading locations...
相似试验
进行中（未招募）
1 期
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product ConcentrationsNCT07338214Zealand Pharma48
招募中
1 期
Phase 1 study to investigate the pharmacokinetic profile and safety of 3 testosterone gel formulations in postmenopausal female participants.2025-522726-12-00Chemo Research S.L.24
招募中
1 期
A study of the safety, tolerability, pharmacokinetics and preliminary efficacy of TNV108 in healthy adults and patients with diabetic peripheral neuropathy2025-524258-32-00Tenvie Therapeutics Inc.108
已完成
1 期
A Phase I study to evaluate the pharmacokinetics, safety, and tolerability of multiple oral doses of obefazimod in patients with mild and moderate hepatic impairment, compared to matched control groups.2023-505299-31-00Abivax32
招募中
1 期
A Phase I study to evaluate the pharmacokinetics, safety and tolerability of multiple oral doses of obefazimod in participants with renal impairment and matched normal kidney function.2024-514561-20-00Abivax48